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ABSTRACT 
 
Aims: To describe a case of systemic sclerosis (SSc) associated with severe alopecia areata (AA) 
responsive to topical and systemic treatments, including vasoactive and immunosuppressive drugs 
(mycophenolate mofetil). 
Presentation of the Case: A 56 year old woman, affected by SSc as from 5 years back, 
developed a rapid hair loss that progressively involved a large area of the scalp. AA was 
diagnosed, after the exclusion of an overlapping systemic lupus erythematosus or fungal infection. 
Treatment with topical steroids and minoxidil, plus mycophenolate mofetil that was introduced for 
interstitial lung disease, led to progressive improvement of alopecia up to a complete resolution 
within 4 months.  
Discussion: This is an interesting observation of SSc complicated by severe AA, which is often 
observed in patients affected by various autoimmune disorders. A possible common pathogenesis 
of AA and SSc is also discussed. 
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1. INTRODUCTION  
 
Systemic sclerosis (SSc) is a connective tissue 
disease characterized by collagen 
overproduction by altered fibroblasts and 
microvascular abnormalities, responsible for both 
skin and visceral organ involvement [1]. While 
typical cutaneous manifestations are largely 
described [1], data about the involvement of the 
scalp in scleroderma patients are scarce. 
Alopecia areata (AA) is a common, non-scarring 
dermatologic condition, characterized by patches 
of scalp hair loss; disease duration varies from 
self-resolving to permanent, while the distribution 
may be focal or widespread to total body. AA is 
often associated with psychological morbidity 
that may negatively affect the patient’s quality of 
life [2,3]. AA is a heterogeneous disorder, 
characterized by  chronic inflammation of the hair 
follicles, the etiology of which remains unclear, 
and the pathogenesis is probably multifactorial. 
The disease might be the consequence of 
immune-system alterations triggered by different 
genetic, environmental, infectious, and/or 
physical (trauma) co-factors [3]. Clinical 
observations revealed that patients with AA are 
often diagnosed together with one or more 
autoimmune disorders, including systemic lupus 
erythematosus (SLE), myasthenia gravis, 
ulcerative colitis, vitiligo, type 1 diabetes, 
thyroiditis, celiac disease, and rheumatoid 
arthritis [3,4]. The association of AA with 
localized scleroderma has also been reported, 
while no cases of AA are described in SSc, to 
our knowledge, up to date. Here, we describe a 
patient with SSc complicated by AA of the scalp.  
 
2. PRESENTATION OF CASE 
 
A 56 year old woman was firstly referred to the 
Rheumatology Unit of the University of Modena 
in 2010. Her past clinical history was 
characterized by Raynaud's phenomenon from 
2009. She developed skin sclerosis of the hands, 
forearms and face, and telangiectasias; 
moreover, at the time of the diagnosis, typical 
scleroderma pattern at videocapillaroscopy (late 
pattern) and positivity to anti-Scl70 antibodies 
were found. After few years, interstitial lung 
disease was detected by high resolution 
computerised tomography. No significant heart 
involvement, including signs of pulmonary 
hypertension at echocardiography, was found 
during the follow-up. The patient was first treated 
with calcium channel blockers. During the 
following years, she suffered recurrent digital 
ulcers, thus iloprost and bosentan were added to 
treatment.  
 
In January 2014, the patient rapidly developed 
hair loss, which progressively involved a large 
area of the scalp (Fig. 1a); moreover, a few 
erythematous scaly, flaky, macular lesions 
appeared on the neck, the trunk, and the arms. 
Thus, in the suspicion of a lupus-like cutaneous 
manifestation, a diagnostic skin biopsy was 
performed. Histopathological examination 
revealed a reduction of the hair follicle cells with 
inflammatory infiltrate in and around the bulbar 
region of hair follicle, along with diffuse collagen 
infiltration of the dermis, consistent with the 
underlying SSc; furthermore, few fungal hyphae 
were found. On the basis of these findings, the 
case was collegially discussed with the 
dermatologists, and diagnosis of AA complicating 
SSc was made, since the presence of hyphae 
was not sufficient to diagnose active cutaneous 
fungal infection. 
 
Patient’s serology was re-evaluated, excluding 
the presence of anti-dsDNA autoantibodies or 
complement consumption. Overall, the suspicion 
of an overlapping syndrome SLE-SSc was 
reasonably excluded.  
 
Topical steroids and minoxidil were administered 
in the ensuing months. Moreover, given the 
coincident progression of patient’s interstitial lung 
disease, mycophenolate mofetil (2 g bid) was 
also added to the therapy. In agreement with the 
dermatologists, no anti-fungal treatment was 
administered. A slow progressive improvement of 
alopecia was observed in the ensuing 4 months, 
leading to a complete resolution (Fig. 1c). 
 
3. DISCUSSION  
 
To the best of our knowledge this is the first 
observation of severe AA associated with SSc, 
even if several hair disorders, including AA, can 
be found in different autoimmune systemic 
diseases and localized scleroderma (3, 4, 7-9). 
Recent clinical investigations considered AA an 
autoimmune disorder due to T cell-mediated hair 
follicle damage. In particular Xing et al. 
demonstrated that cytotoxic CD8(+)/NKG2D(+) T 
cells were both necessary and sufficient for the 
induction of AA in mouse models of disease [5]. 
In our case, the chronic inflammation of hair 
follicles due to the pre-existent seborrhoeic 
dermatitis might be considered as the against 
hair follicles was born, then controlled
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Fig. 1. Alopecia Areata in a patient with systemic sclerosis: 
a. hair loss of the scalp 
b. hair loss progressively involved the scalp; and 
c. Significant improvement after combined therapy with topical corticosteroids and minoxidil, and 
systemic therapy with mycophenolate mofetil 
 
with the local and systemic immunosuppressive 
therapy. Alternatively, a transient stressful 
condition as etiologic trigger could be 
hypothesized; nonetheless, a mere coincidental 
coexistence of AA and SSc cannot be excluded. 
 
Alopecia was firstly described in patients with 
localized form of scleroderma in 1962 [6]; this 
possible association was also observed also in 
the linear subset of scleroderma “en coup de 
sabre” and morphea [7,8], two conditions that 
only sporadically may evolve to SSc [9]. We 
could speculate that both fibrotic and immune-
mediated alterations of SSc might lead to severe 
injury and disappearance of hair follicles, even if 
exceptional, and with the possible contribution of 
unknown co-factors.  
 
No clearly effective treatments for AA are 
available at the present time. Current 
management of AA is primarily symptomatic and 
often directed to mitigate the psychological 
distress [2]. In our patient the combined therapy 
with vasoactive and immunosuppressive drugs 
lead to improvement (Fig. 1c) of hair loss. Even if 
we can not exclude that alopecia could be 
improved spontaneously, combined therapy with 
minoxidil, mycophenolate mofetil, and iloprost 
might have contributed to this improvement. 
However, data from literature on the therapeutic 
effects of mycophenolate mofetil,  iloprost, and 
other prostaglandin analogues in AA are 
conflicting [10,11]. 
 
4. CONCLUSION 
 
This case might be regarded as a peculiar 
overlap of AA appearing in the context of SSc, 
possibly with the pathogenetic link of 
autoimmunity. Alternatively, SSc and AA may be 
just coincident. Clinicians should be aware of this 
rare possibility.  
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